Michael S. Werner acts as a Senior Litigation Counsel at Slater Slater Schulman LLP, possessing over 10 years of impressive legal experience. Michael has litigated numerous mass tort litigation over his career, primarily focusing in the areas of defective medical devices and pharmaceuticals.
Proficient in his practice, Michael believes that effective communication is the key to the success of a case. Individuals seeking representation from Michael have often experienced traumatic and life-altering consequences as a result of failed medical devices or pharmaceutical drugs. Encouraging his clients to tell their story, and leaving predetermined assumptions at the wayside, Michael assures his clients that their voice will be heard by advocating for the results they truly desire.
Michael’s compassion for his clients and impressive litigation abilities have earned him several prominent recognitions in the legal community. He has been designated a Super Lawyer New York Metro Rising Star each year since 2015. Michael is also a proud member of the Nassau County Bar Association and Suffolk County Bar Association.
In addition to his mass tort experience, Michael has an extensive background in state court litigation involving personal injury, general liability, and commercial litigation matters. He is intimately involved in the prosecution of claims involving the James L. Zadroga 9/11 Health and Compensation Act—supporting those injured as a result of exposure to toxins at the “Ground Zero” site—as well as the Child Victims Act, which provides an avenue of recovery for survivors of childhood sexual abuse. Additionally, Michael was heavily involved in In re: Long Island Power Authority, Hurricane Sandy Litigation—a class action lawsuit seeking to provide monetary recovery for residents of Long Island that were afflicted by “Superstorm Sandy.”
Michael has litigated various mass torts and coordinated proceedings for well-known defective medical devices and pharmaceuticals, including Accutane, Camp Lejeune, DePuy ASR, and Zimmer Nexgen. Michael also acted as liaison counsel for all cases filed in New York County Supreme Court in the Plavix Coordinated Proceeding. He is currently actively litigating claims involving Roundup herbicide, Allergan BIOCELL breast implants, Ethicon Surgical Staplers, Uloric (Febuxostat), and Zantac (Ranitidine), among others.
He received his Bachelor of Science (B.S.) from Baruch College in 2004, and his Juris Doctor (J.D.) from St. John’s University School of Law in 2008—where he served as the Managing Editor of the American Bankruptcy Institute Law Review. He was admitted to the New York State Bar in 2009 and the U.S. District Court for the Eastern and Southern Districts of New York in 2012. Michael joined the team at Slater Slater Schulman in 2018.
- New York State
- United States District Court, Eastern District of New York
- United States District Court, Southern District of New York